DFM Platform
DFM Funding Monitor

Accurate Reliable Portable and Rapid Methods And Technologies for DetectIon of GHB Substances and Prevention Against Different Forms of VioLence and AssauLt SuppOrted by These Drugscore

ARMADILLO · Horizon Europe grant · 2024-10-01–2027-09-30

EC contribution

€4,105,150

Total cost

€4,922,875

Beneficiaries

17
About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-CL3-2023-FCT-01 · scheme HORIZON-IA · topic HORIZON-CL3-2023-FCT-01-02. CORDIS record →

Objective

ARMADILLO aims to equip Law Enforcement Authorities (LEAs) and more particularly, Police Authorities and Forensic Institutes, with a holistic, ground-breaking, easy-to-use, portable toolset that rapidly detects GHB concentrations in urine, saliva and beverages. To realize this, the project will focus on the design and development of in-situ GHB detection systems, integrating advanced optical spectroscopy and electrochemical techniques for precise GHB identification in the different matrices. Both optical and electrochemical detection techniques will be integrated to portable readers capable of quantitative GHB on-site determination. The optical spectroscopy techniques will explore surface-enhanced signal-based approaches (Raman and fluorescence) alongside paper strip methods, while electrochemical detection will combine a specialized fluidics module and NAD/NADH electrodes. In parallel, GHB-specific antibodies will be developed aiming to further enhance its detection selectivity and accuracy. The project will prioritize the enhanced collection and sharing of forensic evidence, emphasizing on forensics' data management and ensuring interoperability and harmonization across systems. By integrating data fusion mechanisms, it will provide reliable, safe, and court-proof forensic evidence, while also leveraging the potential of AI for refined Raman analysis. Concurrently, it will undertake a comprehensive risk assessment to bolster prevention strategies against drug-facilitated violence and assault, all while standardizing user interfaces and employing advanced visualization and reporting techniques. In order to avoid clinical trials and comply with the ethical considerations including the privacy and safety of any involved human subject, ARMADILLO will assess the accuracy, sensitivity and specificity of its sensing technologies using synthetic samples that simulate a wide range of GHB concentrations in urine and saliva samples.

Beneficiaries (17)

OrganisationCountryRoleEC contributionSME
NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""" EL coordinator €654,375
NETCOMPANY S.A. LU participant €393,750
INSTITUT ZA KORPORATIVNE VARNOSTNE STUDIJE LJUBLJANA SI participant €307,750
RISA SICHERHEITSANALYSEN GMBH DE participant €301,875 Yes
CHAROKOPEIO PANEPISTIMIO EL participant €280,000
JOBST TECHNOLOGIES GMBH DE participant €278,250
ARTHUR'S LEGAL BV NL participant €261,275 Yes
ABCALIS GMBH DE participant €240,625 Yes
KENTRO MELETON ASFALEIAS EL participant €230,000 Yes
SISAMINISTERIO (SM) FI participant €227,500
SINOPSIS SOCIALLY INTEGRATED INNOVATION S.R.L. RO participant €219,625 Yes
TEXNOLOGIES FOTONIKON KAI HLEKTRONIKON SYSTHMATVN AE EL participant €212,625 Yes
AYUNTAMIENTO DE MURCIA ES participant €205,000
INSPECTORATUL GENERAL AL POLITIEI MD participant €115,000
STOWARZYSZENIE POLSKA PLATFORMA BEZPIECZENSTWA WEWNETRZNEGO PL participant €105,625 Yes
KOMENDA WOJEWODZKA POLICJI Z SIEDZIBA W RADOMIU PL participant €71,875
SHEFFIELD HALLAM UNIVERSITY UK associatedPartner

Get the DFM funding briefing — free

New EU defence calls, tenders and awards in your inbox.

Countries
Sectors
Sources

We store your email only to send the DFM briefing/alerts and to add you to DFM Analysis. Unsubscribe anytime.

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.